"","Num","POD","SD","%","Genes","KE"
"GO:0004620","2","8.33744192153685e-05","0.065198626126909","40","hmox1a, lpl","INHIBITION PHOSPHOLIPASE A"
"GO:0016055","3","8.67945497594956e-05","0.0741691697012931","13.04","csnk2b, fzd7a, wnt1","ALTERATION WNT PATHWAY"
"GO:0050663","3","9.60063352446122e-05","0.128575305008263","10","kars, lpl, tmsb4x","RELEASE CYTOKINE"
"ABNORMAL OVARIAN MORPHOLOGY","4","0.000158261798882863","0.0836592961416621","10.81","nup107, pik3ca, ptena, sdhc","PROMOTION OVARIAN GRANULAR CELL TUMORS; DECREASED OVARIAN E2; PROMOTION OVARIAN ADENOMAS"
"ABNORMAL CIRCULATING CHOLESTEROL CONCENTRATION","4","0.000210767955211325","0.219366979384424","36.36","hsd3b7, lipf, lpl, nup107","DECREASED CHOLESTEROL; PERTURBATION OF CHOLESTEROL"
"GO:0060291","2","0.000216871632538698","0.08817274658404","14.29","ephb2b, ptena","DECREASED LONG-TERM POTENTIATION LTP"
"ABNORMALITY OF THE ENDOMETRIUM","5","0.000217661001463131","0.0489579215816277","45.45","msh6, pik3ca, ptena, sdhc, thoc6","INCREASED HYPERPLASIA GLANDULAR EPITHELIAL CELLS OF ENDOMETRIUM; INCREASE HYPERPLASIA GLANDULAR EPITHELIAL CELLS OF ENDOMETRIUM; INCREASED ADENOSQUAMOUS CARCINOMAS OF ENDOMETRIUM"
"SMOOTH MUSCLE CELL PROLIFERATION","3","0.000235429572816211","0.153416796280767","11.54","calcrla, hmox1a, ptena","HYPERTROPHY/HYPERPLASIA SMOOTH MUSCLE"
"CYTOPLASMIC RIBOSOMAL PROTEINS","11","0.000241571170530789","0.0593847656672613","7.64","rpl19, rpl21, rpl34, RPL37A, rpl38, rplp0, rps19, rps25, rps29, rps3, rps4x","OCCURRENCE CYTOPLASMIC VACUOLIZATION PODOCYTE"
"CTOME CELLULAR RESPONSE TO HYPOXIA","7","0.000274149590702174","0.127113457662363","16.28","psmb6, psmc6, psmd1, psmd12, psmd14, psmd8, vegfaa","N/A HYPOXIA"
"GO:0001909","2","0.000296451007756762","0.546581469203854","33.33","arrb2b, crk","INCREASE CYTOTOXICITY"
"GO:0006898","6","0.000306188467333887","0.135468399188933","15.79","arrb2b, calcrla, hsp90b1, ntf3, rac1a, tfa","REDUCTION VITELLOGENIN ACCUMULATION INTO OOCYTES AND OOCYTE GROWTH/DEVELOPMENT; INCREASED LDL UPTAKE"
"TUBE FEEDING","4","0.000308667899139459","0.135524113569313","23.53","csnk2b, ppp2r1a, ppp2r1b, psat1","INHIBITION FEEDING"
"SIGNALING OF HEPATOCYTE GROWTH FACTOR RECEPTOR","3","0.00031130641796981","0.219270496973397","8.82","crk, pik3ca, ptena","OCCURRENCE CYTOPLASMIC VACUOLIZATION HEPATOCYTE; OCCURRENCE BALLOONING DEGENERATION HEPATOCYTE"
"REGULATION OF WNT SIGNALING PATHWAY","8","0.00032745728812598","0.0979624922314548","10.13","ppp2r1a, ppp2r1b, psmb6, psmc6, psmd1, psmd12, psmd14, psmd8","INHIBITION WNT PATHWAY"
"HYPERACTIVITY","7","0.000333417523022854","0.128621959298094","14","atrx, cacna1ba, msh6, pik3ca, ppp2r1a, ppp2r1b, psmd12","INDUCTION ATAXIA PARALYSIS OR HYPERACTIVITY; INCREASED ATAXIA PARALYSIS OR HYPERACTIVITY; N/A ATAXIA PARALYSIS OR HYPERACTIVITY"
"LIPID ACCUMULATION IN HEPATOCYTES","4","0.000369248747522557","0.125092174241713","12.5","adka, aldob, farsb, lipf","INCREASE PRENEOPLASTIC FOCI HEPATOCYTES"
"GO:0001816","14","0.000371325722281737","0.0780899676496966","11.67","adcyap1b, arrb2b, cd40, cebpb, f11r.1, hmox1a, kars, lipf, lpl, rac1a, roraa, rps3, tfa, tmsb4x","NON-NEURONAL PRODUCTION OF TNF EPITHELIAL IRRITATION; PRODUCTION OF NERVE GROWTH FACTOR  EPITHELIAL IRRITATION; NON-NEURONAL PRODUCTION OF IL-8/CXCL1 EPITHELIAL IRRITATION"
"GO:0019882","6","0.000377068957185894","0.148052638311794","10.17","psmb6, psmc6, psmd1, psmd12, psmd14, psmd8","GENERATION OF NOVEL EPITOPES  ANTIGEN PRESENTATION"
"GO:1903009","6","0.000377068957185894","0.148052638311794","17.65","psmb6, psmc6, psmd1, psmd12, psmd14, psmd8","DECREASE GTPCH-1"
"GO:0006633","3","0.000382605225857089","0.381318389661385","10.34","eif6, lpl, nr1h3","SYNTHESIS DE NOVO FA; INCREASED DE NOVO FA SYNTHESIS; INCREASED DE NOVO FA SYNTHESIS"
"MORTALITY AGING","6","0.000386777522954501","0.16554355569091","23.08","atrx, calcrla, lipf, msh6, pik3ca, rbm8a","REDUCED FITNESS OR EVEN MORTALITY ACIDOSIS HYPOVOLEMIC SHOCK AND ORGAN DYSFUNCTION; INCREASE MORTALITY; INCREASED MORTALITY"
"BREAST CANCER PATHWAY","5","0.000404045912546026","0.26602138313692","4.39","csnk2b, pik3ca, ptena, tp53, wnt1","N/A BREAST CANCER"
"GO:0006412","13","0.000420929937249593","0.0676449096362233","12.04","eef1a1l1, eif3ea, eif4ea, eif6, rpl19, rpl21, rpl34, RPL37A, rpl38, rps19, rps29, rps3, rps4x","ALTERED PROTEIN PRODUCTION"
"ABNORMALITY OF THE OVARY","7","0.000446465869238859","0.15011349686199","12.28","msh6, nup107, pik3ca, ptena, sdhc, thoc6, tp53","REDUCED PROSTAGLANDINS OVARY"
"GO:0007249","6","0.000461171357990325","0.186581971123719","13.95","cd40, hmox1a, rock1, roraa, tfa, ube2na","INHIBITION NUCLEAR FACTOR KAPPA B NF-KB"
"GO:0042701","5","0.000478875174163222","0.24148007398836","14.71","anapc10, hsp90aa1.1, mapk12a, pik3ca, plk1","DECREASED PROGESTERONE FROM CORPUS LUTEUM"
"LOCOMOTORY BEHAVIOR","3","0.000537547289936959","0.455628478659995","4.84","aph1b, arrb2b, ptena","REDUCED SWIMMING SPEED; REDUCED SWIMMING PERFORMANCE"
"ABNORMAL NASAL MORPHOLOGY","19","0.000558080546695484","0.0499880015524865","12.26","atic, atrx, cdc42, ctsk, exosc2, hoxb1a, pik3ca, plod1a, ppp2r1a, ppp2r1b, psat1, psmd12, ptena, rac1a, rbm8a, rps19, rps29, tfap2a, thoc6","INCREASE SITE OF CONTACT NASAL TUMORS"
"GO:0043542","7","0.000564753781351517","0.181025682896503","20","cd40, csnk2b, hmox1a, pik3ca, ptena, tek, tmsb4x","INCREASED MIGRATION ENDOTHELIAL CELLS"
"JNK CASCADE","3","0.000577947222388021","0.488454336186593","13.64","cdc42, tfa, ube2na","ACTIVATION JNK"
"GO:0042116","3","0.000595696645893074","0.331808007409238","20","kars, nr1h3, roraa","INCREASED ACTIVATION AND RECRUITMENT OF HEPATIC MACROPHAGES KUPFFER CELLS"
"FAT MALABSORPTION","2","0.000607134855687763","0.604739671993519","50","hsd3b7, lipf","INDUCTION MICROVESICULAR FAT"
"GO:0045444","7","0.000642158216742089","0.213670553229258","17.07","adrb1, arntl1a, cebpb, foxo1b, lpl, roraa, wnt1","INCREASED ADIPOGENESIS"
"GO:0044414","3","0.000679223330467729","0.342058972930853","7.5","calr3a, rac1a, tuba8l3","SUPPRESSION IMMUNE SYSTEM"
"GO:0001775","23","0.000728178212896824","0.0462222797063368","11.73","arrb2b, cat, cd40, cdc42, cebpb, csnk2b, f11r.1, hmox1a, kars, msh6, nme2b.2, nr1h3, pik3ca, psmd1, psmd12, psmd14, rac1a, rock1, roraa, rps3, tfa, tp53, wnt1","ACTIVATION DENDRITIC CELLS"
"GO:0006954","16","0.000767508571008184","0.0720528303746265","13.68","adcyap1b, calcrla, cd40, cebpb, f11r.1, hmox1a, kars, lipf, lpl, nr1h3, pparab, rac1a, roraa, rps19, tek, tmsb4x","INCREASE INFLAMMATION; INCREASE INFLAMMATION CORNEAL CELLS; INFILTRATION INFLAMMATORY CELLS; INCREASED INFLAMMATION; CHRONIC COUGH RESPIRATORY IRRITABILITY"
"PURE RED CELL APLASIA","3","0.000778315858038636","0.597190883323675","15","rps19, rps29, tp53","N/A METHEMOGLOBINEMIA DECREASED HEMOGLOBIN HEMATOCRIT RED BLOOD CELL NUMBER"
"REGULATION OF ATPASE ACTIVITY","5","0.000786357372363662","0.248069395593839","31.25","aldob, gtf2h4, msh6, tfa, tp53","INHIBITION CA++ ATPASE"
"GO:0030163","19","0.00085656141785733","0.0635509450958396","12.42","anapc10, arntl1a, arrb2b, cdc20, ctsk, foxo1b, hsp90b1, plk1, psmb6, psmc6, psmd1, psmd12, psmd14, psmd8, ptena, rchy1, rock1, usp14, wnt1","INCREASED CATABOLISM OF MUSCLE PROTEIN"
"SOMATIC MUTATION","6","0.000859367266217482","0.230611349694139","7.14","ar, foxo1b, msh6, pik3ca, ptena, tp53","INCREASED INDUCED MUTATIONS IN CRITICAL GENES; INCREASE MUTATIONS; INCREASE MUTATIONS IN CRITICAL GENES"
"ABNORMAL CIRCULATING ESTROGEN LEVEL","3","0.000913927646220446","0.577393626209884","21.43","nup107, pik3ca, tp53","INCREASED CIRCULATING ESTROGEN LEVELS"
"ABNORMAL FORM OF THE VERTEBRAL BODIES","6","0.000925119791943481","0.231581654275107","18.18","atrx, bmp1a, orc1, ptena, rps19, wnt1","CLONAL EXPANSION/CELL PROLIFERATION TO FORM ALTERED HEPATIC FOCI AHF"
"ABNORMALITY OF ADRENAL PHYSIOLOGY","3","0.00093394909001641","0.574529496016743","3.26","lipf, pik3ca, tp53","INCREASE RENAL PATHOLOGY DUE TO VTG DEPOSITION; DECREASED RENAL ABILITY TO DILUTE URINE; OCCURRENCE KIDNEY TOXICITY; INCREASED KIDNEY FAILURE"
"GO:0016310","12","0.000935677495619841","0.0818701863320125","9.6","adka, ckmt1, csnk2b, ephb2b, fyna, mapk12a, nme2b.2, pik3ca, plk1, riok1, rock1, tek","ACTIVATION SP1"
"G VEGF SIGNALING PATHWAY","4","0.000961938710775046","0.345321128786378","19.05","cdc42, pik3ca, rac1a, vegfaa","REDUCED PRODUCTION VEGF"
"TRIGLYCERIDE METABOLIC PROCESS","4","0.00099279471718898","0.326020208546643","25","cat, lipf, lpl, nr1h3","ACCUMULATION TRIGLYCERIDE"
"GO:0048870","20","0.00102105421555689","0.0600200783946782","10","arrb2b, cd40, cdc42, crk, csnk2b, f11r.1, hmox1a, hsd3b7, kars, ntf3, pik3ca, ptena, rac1a, rock1, rps19, tbx5a, tek, tfa, tmsb4x, tp53","INCREASED MOTILITY"
"G GLUTATHIONE METABOLISM","2","0.00106912245486277","0.807180813091589","25","gsr, rrm2","DEPLETION GSH"
"LUNG FIBROSIS","3","0.00109569120654241","0.452530270961472","8.33","cebpb, hmox1a, mt2","LUNG FIBROSIS"
"GO:0048813","3","0.00110045589525067","0.409361144913634","23.08","cdc42, ephb2b, ptena","ABERRANT DENDRITIC MORPHOLOGY"
"ABNORMALITY OF THE LIVER","21","0.00110790667290081","0.0574237876409726","2.8","adka, aldob, atrx, ctsk, farsb, gale, hmox1a, hsd3b7, lipf, lpl, msh6, ndufs2, ndufv2, pik3ca, ptena, rbm8a, sdha, sdhc, tfa, tp53, tpi1b","INCREASED INDUCTION OF UDPGT'S IN LIVER; INCREASED LIVER STEATOSIS; INCREASED LIVER STEATOSIS; N/A HEPATOTOXICITY HEPATOPATHY INCLUDING A CONSTELLATION OF OBSERVABLE EFFECTS; INDUCTION SUSTAINED HEPATOTOXICITY"
"CTOME ACTIVATION OF GENE EXPRESSION BY SREBF SREBP","2","0.00114618809845069","0.157688952917421","16.67","fdps, pparab","UP REGULATION SREBF2"
"ENDOMETRIAL CANCER","3","0.0011609344922913","0.547935964418477","4.41","pik3ca, ptena, tp53","INCREASE ENDOMETRIAL ADENOCARCINOMAS"
"UPPER MOTOR NEURON DYSFUNCTION","17","0.00118351259617387","0.0749557651993231","3.59","atrx, bckdha, cacna1ba, csnk2b, msh6, ndufs2, ndufv2, nup107, pdhx, pik3ca, psat1, ptena, roraa, sdha, tbp, tp53, tpi1b","DECREASE HISTAMINERGIC NEURON EXCITATION; OCCURRENCE CYTOPLASMIC VACUOLIZATION BILE DUCT CELL; OCCURRENCE CYTOPLASMIC VACUOLIZATION KUPFFER CELL"
"GO:0042060","11","0.00123311756964737","0.110074897993106","12.5","arrb2b, cd40, cdc42, crk, f11r.1, hmox1a, pik3ca, pparab, ptena, rac1a, tp53","FAILURE IN VASCULAR REPAIR MECHANISMS UNRESOLVED BLOOD LOSS HEMORRHAGE"
"ABNORMAL LUNG MORPHOLOGY","14","0.00124592179409526","0.0803823750168014","10.94","agrn, cacna1ba, calcrla, cdc42, farsb, lipf, nup107, plod1a, psat1, psmd12, ptena, rac1a, tbx5a, tp53","INCREASE ADENOMAS/CARCINOMAS BRONCHIOLOALVEOLAR"
"HEPATOCELLULAR CARCINOMA","3","0.00125921099931097","0.539083563964303","23.08","msh6, pik3ca, tp53","FORMATION HEPATOCELLULAR AND BILE DUCT TUMORS; INCREASE ADENOMAS/CARCINOMAS HEPATOCELLULAR; TUMORIGENESIS HEPATOCELLULAR CARCINOMA"
"PYRUVATE METABOLIC PROCESS","11","0.00126970688006737","0.111687732411345","19.64","aldob, eif6, ndc1, nup107, nup37, nup43, pdhx, pgam2, pparab, tpi1b, vdac1","INHIBITION 4-HYDROXYPHENYL-PYRUVATE DIOXYGENASE HPPD ENZYME"
"ABNORMALITY OF THE PITUITARY GLAND","5","0.00132374350192669","0.289521738262066","10.42","ar, msh6, nup107, pik3ca, tp53","INCREASED ADENOMAS PITUITARY"
"GO:0001525","5","0.00132486905489842","0.292979888488073","13.51","calcrla, mt2, rps29, tek, vegfaa","REDUCTION ANGIOGENESIS; INCREASED ANGIOGENESIS"
"ABNORMALITY OF THE ABDOMINAL ORGANS","22","0.00133623344407477","0.0562359783950104","13.02","adka, aldob, atrx, bckdha, ctsk, farsb, gale, hmox1a, hsd3b7, lipf, lpl, msh6, ndufs2, ndufv2, pik3ca, ptena, rbm8a, sdha, sdhc, tfa, tp53, tpi1b","IMPAIRED DEVELOPMENT OF REPRODUCTIVE ORGANS"
"GO:0009611","13","0.0013612636025436","0.100241610171924","11.61","arrb2b, cd40, cdc42, crk, f11r.1, hmox1a, hoxb13a, pik3ca, pparab, ptena, rac1a, tp53, wnt1","ACCUMULATION DAMAGED MITOCHONDRIAL DNA"
"GO:0040011","24","0.00138689634290368","0.0505101577640578","10.57","agrn, arrb2b, cd40, cdc42, crk, csnk2b, ephb2b, f11r.1, hmox1a, hsd3b7, kars, ntf3, pik3ca, ppid, ptena, rac1a, rock1, rps19, tbx5a, tek, tfa, tmsb4x, tp53, usp14","INCREASED LOCOMOTION; INCREASED MUSCULAR WAVES IN FOOT; DECREASED LOCOMOTION"
"GO:0046903","23","0.00140765259940598","0.0505645049837194","9.96","adcyap1b, arntl1a, cacna1ba, cat, cd40, csnk2b, gad2, hmox1a, kars, lpl, neurog1, nme2b.2, nr1h3, ppid, psmd1, psmd12, psmd14, rac1a, rock1, sirt3, tfa, tmsb4x, tuba8l3","SUPPRESSION VLDL SECRETION; INCREASE MUCIN PRODUCTION; INCREASED SECRETION OF LOCAL GROWTH FACTORS"
"REGULATION OF CELL DEATH","33","0.00140817597464759","0.0339071918175392","12.31","adcyap1b, aph1b, ar, arrb2b, atf4a, cat, cd40, cdc42, cebpb, ctnnbl1, foxo1b, fyna, hmox1a, hsp90b1, mt2, nme2b.2, ntf3, parp2, pik3ca, plk1, pparab, ppid, ppp2r1b, ptena, rps3, tek, tfa, tfap2a, thoc6, tp53, vdac1, vegfaa, wnt1","N/A CELL INJURY/DEATH"
"GO:0005488","117","0.00141241082439707","0.00980008251557094","10.87","adcyap1b, adrb1, adssl, agrn, alyref, ar, arntl1a, arpc1a, arrb2b, atf4a, atrx, bmp1a, calb2b, calr3a, cat, cd40, cdc20, cdc42, cebpb, ckmt1, cpsf6, csnk2b, cwc15, cyp24a1, cyp2aa3, eef1a1l1, eif3ea, eif4ea, eif6, enoph1, ephb2b, exosc2, f11r.1, farsb, foxo1b, fyna, fzd7a, gad2, gcat, gosr2, grhl2b, gsr, gtf2b, gtf2h4, hmgcrb, hmox1a, hoxb13a, hoxb1a, hoxb5a, hsp90aa1.1, hsp90b1, kars, lpl, mapk12a, meis2b, mmp24, msh6, mt2, ndufs2, ndufv2, neurog1, nme2b.2, nr1h3, ntf3, nucb2a, orc1, parp2, pik3ca, plk1, plod1a, polr1e, polr2j, pparab, ppid, ppp1caa, psat1, psmc6, psmd14, pvalb2, rac1a, rbm22, rbm8a, rchy1, riok1, rock1, roraa, rorb, rpa1, rpl19, rplp0, rps19, rps29, rps3, rps4x, rrm2, sdha, sdhc, sirt3, smad1, sox1a, sox9b, srp72, tbp, tbx5a, tek, tfa, tfap2a, thoc6, tmsb4x, tp53, tpi1b, tuba8l3, ube2e2, ube2na, vegfaa, wnt1, zgc-55733","INCREASED BINDING OF CHEMICALS TO 2U SERUM"
"PEPTIDYL LYSINE MODIFICATION","9","0.0014153853426571","0.139396952758855","12.68","atrx, gtf2b, ndc1, nup107, nup37, nup43, plod1a, pwp1, sirt3","N/A COVALENT BINDING TO PROTEIN POSSIBLY LYSINE RESIDUE"
"NEOPLASM OF THE SKIN","7","0.00141727322659667","0.184991519179059","21.21","fdps, krt94, msh6, pik3ca, ptena, sdhc, tp53","SENSITISATION SKIN"
"REGULATION OF APPETITE","2","0.00143519677221627","0.0886360482115011","33.33","nucb2a, pparab","INCREASED APPETITE AND HUNGER"
"ABNORMALITY OF THE BLADDER","7","0.00143824720219805","0.177726055984885","13.46","atrx, glud1b, pik3ca, plod1a, psmd12, sdha, tbp","REDUCED POSTERIOR SWIM BLADDER INFLATION; REDUCED ANTERIOR SWIM BLADDER INFLATION; INCREASE URINARY BLADDER CALCULI"
"ABNORMALITY OF BLOOD AND BLOOD FORMING TISSUES","29","0.00145552308345997","0.0417952950910399","7.18","aldob, atrx, cat, cd40, cdc42, ctsk, ephb2b, farsb, gsr, hmox1a, hsd3b7, krt94, lipf, msh6, ndufs2, ndufv2, pik3ca, plod1a, ptena, rbm8a, rps19, rps29, sdha, sdhc, srp72, tek, tfa, tp53, tpi1b","DAMAGING RED BLOOD CELLS; HEMOLYSIS"
"RESPONSE TO NITRIC OXIDE","3","0.00147718099772084","0.482930989620399","42.86","crk, foxo1b, mt2","DECREASED NITRIC OXIDE"
"INCREASED SUSCEPTIBILITY TO FRACTURES","4","0.00150224588485506","0.374452327030777","11.43","ctsk, ptena, tp53, wnt1","INCREASED DISEASE SUSCEPTIBILITY"
"ABNORMALITY OF REPRODUCTIVE SYSTEM PHYSIOLOGY","9","0.00150636013872974","0.128276583191764","8.74","ar, atrx, nup107, pik3ca, psat1, psmd12, rps4x, thoc6, tp53","N/A IMPAIRMENT OF REPRODUCTIVE CAPACITY"
"CHOLESTASIS","9","0.00154904996772302","0.134774358066451","25.71","adka, aldob, farsb, gale, hsd3b7, lipf, lpl, tp53, tpi1b","INCREASED CHOLESTASIS; CHOLESTASIS PATHOLOGY"
"ABNORMAL LIVER MORPHOLOGY","17","0.00156538502315426","0.0757633949334478","14.29","adka, aldob, atrx, ctsk, farsb, gale, hmox1a, hsd3b7, lipf, lpl, ndufs2, ndufv2, pik3ca, ptena, rbm8a, sdha, tp53","INDUCTION LIVER “DYSFUNCTIONAL” CHANGES BY CGA 330050; INFLAMMATION LIVER; N/A LIVER FIBROSIS; INCREASE RBC CONGESTION IN LIVER; INCREASE LIVER AND SPLENIC HEMOSIDEROSIS; REDUCTION VITELLOGENIN SYNTHESIS IN LIVER; INCREASE VITELLOGENIN SYNTHESIS IN LIVER; FORMATION LIVER FIBROSIS; FORMATION LIVER TUMOR"
"GO:0006629","21","0.00157079731405357","0.051283227412511","10.19","agrn, cat, cdc42, crk, csnk2b, cyp24a1, eif6, fdps, hsd11b1la, hsd3b7, lipf, lpl, nr1h3, pik3ca, pparab, ppp2r1b, ptena, rdh10a, roraa, sirt3, tek","ALTERATION LIPID METABOLISM"
"GLOMERULAR SCLEROSIS","3","0.00157915413163526","0.544490088538177","21.43","nup107, sdha, sdhc","DECREASED GLOMERULAR FILTRATION"
"GO:1904019","4","0.00167076682078261","0.396433696531839","18.18","arrb2b, cd40, hmox1a, tek","DECREASE APOPTOSIS OF CILIATED EPITHELIAL CELLS"
"DECREASED BODY WEIGHT","25","0.001674855395234","0.0527729598865882","11.06","adka, aldob, atrx, bmp1a, cacna1ba, cyp24a1, farsb, gale, hsd3b7, krt94, lipf, msh6, ndufs2, ndufv2, orc1, pdhx, pik3ca, psat1, psmd12, ptena, rps19, rps29, sdha, sdhc, tp53","DECREASED BODY WEIGHT"
"CTOME SIGNALING BY EGFR","2","0.00172868780597539","0.85884896759919","25","cdc42, pik3ca","ACTIVATION EGFR"
"ABNORMAL RESPIRATORY SYSTEM MORPHOLOGY","18","0.00173132889424725","0.0612496204377602","12.24","agrn, atrx, cacna1ba, calcrla, cat, cdc42, ctsk, farsb, lipf, msh6, nup107, plod1a, psat1, psmd12, ptena, rac1a, tbx5a, tp53","INCREASED RESPIRATORY DISTRESS/ARREST"
"GO:0004872","16","0.00174214294073061","0.0788286263107897","6.69","adcyap1b, adrb1, ar, arrb2b, calcrla, ednrab, ephb2b, fzd7a, nr1h3, ntf3, pparab, roraa, rorb, tek, vegfaa, wnt1","ACTIVATION PXR/SXR"
"REGULATION OF PROTEOLYSIS","17","0.00175496955448944","0.0729335102489647","15.18","aph1b, arrb2b, cdc20, fyna, mt2, nr1h3, plk1, psmd14, ptena, rchy1, rock1, rps3, tfa, tp53, usp14, vegfaa, wnt1","IMPAIRED PROTEOSTASIS"
"GO:0003158","5","0.00183057841675796","0.24698816399654","20.83","csnk2b, f11r.1, gstm, hoxb5a, rock1","IMPAIRMENT ENDOTHELIAL NETWORK"
"POSITIVE REGULATION OF GENE EXPRESSION","24","0.00183107993307808","0.0479754423484982","13.26","adcyap1b, ar, arrb2b, atf4a, cd40, cebpb, eif3ea, eif6, ephb2b, hmox1a, lpl, mt2, polr1e, ptena, rbm22, rock1, roraa, rps3, rps4x, smad1, tbp, tfap2a, tp53, vegfaa","ALTERED GENE EXPRESSION"
"GO:0007051","5","0.00193255631173012","0.14060325040014","18.52","atrx, cdc20, plk1, ppp2r1b, rps3","DISORGANIZATION SPINDLE"
"GO:0005102","24","0.00196912860574053","0.0547326807665772","11.54","adcyap1b, adrb1, ar, arntl1a, arrb2b, bmp1a, cat, cdc42, cebpb, crk, csnk2b, ephb2b, f11r.1, gtf2b, hsp90b1, lpl, ntf3, ppid, ptena, rqcd1, tbp, tfa, tp53, wnt1","DECREASED TESTOSTERONE BINDING TO ANDROGEN RECEPTOR HYPOTHALAMUS"
"GO:0019904","17","0.00197580485787028","0.0793746448552483","13.82","adrb1, ar, arrb2b, atrx, cd40, cdc42, crk, csnk2b, f11r.1, hoxb1a, polr2j, pparab, ptena, rqcd1, srp72, tp53, wnt1","N/A INTERFERENCES WITH SH-/SELEN-PROTEINS"
"GO:0099536","11","0.00201063225547738","0.116416769305055","9.91","adcyap1b, agrn, arrb2b, cacna1ba, cdc20, ephb2b, gad2, ntf3, ptena, usp14, vdac1","DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN; DECREASED NEURONAL NETWORK FUNCTION IN ADULT BRAIN"
"GO:0007009","2","0.00204270517775327","0.776896831077022","22.22","ar, ptena","NARCOSIS"
"GO:0045333","9","0.00207649385225124","0.142019749747838","12.5","cat, cs, ndufs2, ndufv2, pik3ca, sdha, sdhc, sirt3, uqcrh","INCREASE OXIDATIVE METABOLISM"
"GO:0006281","12","0.0021668845659512","0.094740489267187","14.12","atrx, gtf2h4, msh6, parp2, polr2j, psmd14, rchy1, rpa1, rps3, tp53, ube2na, xab2","N/A INSUFFICIENT OR INCORRECT DNA REPAIR; INCREASED INSUFFICIENT REPAIR OR MIS-REPAIR OF PRO-MUTAGENIC DNA ADDUCTS; OVERWHELMED MITOCHONDRIAL DNA REPAIR MECHANISMS; INCREASED DNA DAMAGE-REPAIR"
"RESPONSE TO REACTIVE OXYGEN SPECIES","7","0.00216698244166345","0.172943201832794","12.5","cat, crk, foxo1b, fyna, hmox1a, mt2, rps3","INCREASED REACTIVE OXYGEN SPECIES"
"RENAL TUBULAR DYSFUNCTION","3","0.00217869168785339","0.474242049859943","11.54","aldob, ndufs2, ndufv2","INCREASE HYPERPLASIA RENAL TUBULAR CELLS; INCREASE CYTOTOXICITY RENAL TUBULAR CELL; INCREASE ADENOMAS/CARCINOMAS RENAL TUBULAR; OCCURRENCE RENAL PROXIMAL TUBULAR NECROSIS"
"G TGF BETA SIGNALING PATHWAY","4","0.00219887068303588","0.333890686052758","5.88","ppp2r1a, ppp2r1b, rock1, smad1","ACTIVATION TGF-BETA PATHWAY; UP REGULATION TGFBETA1 EXPRESSION"
"GO:0046983","24","0.00223184889251963","0.0536293021657759","12.18","adrb1, ar, arntl1a, atic, cat, cebpb, f11r.1, gad2, gale, gstm, hmox1a, kars, lpl, neurog1, plod1a, polr2j, ppp2r1b, rchy1, rps19, rqcd1, rrm2, tfap2a, tp53, tpi1b","DIMERIZATION AHR/ARNT; REDUCED DIMERIZATION ARNT/HIF1-ALPHA"
"G OOCYTE MEIOSIS","6","0.00223599697655655","0.171520040674141","15","anapc10, ar, cdc20, plk1, ppp2r1a, ppp2r1b","REDUCED MEIOTIC PROPHASE I/METAPHASE I TRANSITION OOCYTE"
"CTOME FOXO MEDIATED TRANSCRIPTION","3","0.00223684571020605","0.483289394908375","10.71","cat, foxo1b, sirt3","ACTIVATION FOXO"
"HEART DEVELOPMENT","14","0.00230875046423421","0.0896529668012426","11.11","arrb2b, calcrla, cdc42, grhl2b, ndufv2, parp2, pparab, ptena, rock1, smad1, tbx5a, tek, tp53, vegfaa","ALTERED LARVAL DEVELOPMENT; IMPAIRED DEVELOPMENT"
"MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION","2","0.00237978382850208","0.334624445441579","20","rac1a, rps3","DEPOLYMERIZATION MICROTUBULE"
"ABNORMAL RENAL TUBULE MORPHOLOGY","2","0.00240619461047645","1.04758632901282","22.22","ndufs2, nup107","OCCURRENCE CYSTIC DILATATION RENAL TUBULE; OCCURRENCE CYTOPLASMIC VACUOLIZATION RENAL TUBULE"
"GO:0050673","7","0.00240652655964673","0.163877769351586","8.54","ar, cdc42, cebpb, hmox1a, nme2b.2, ptena, tek","INCREASE REGENERATIVE CELL PROLIFERATION TUBULAR EPITHELIAL CELLS; INCREASE REGENERATIVE CELL PROLIFERATION TERMINAL BRONCHIOLAR EPITHELIAL CELLS"
"GO:0072358","14","0.00248830656900271","0.0948169262104691","12.61","calcrla, cd40, cdc42, ephb2b, foxo1b, hmox1a, hoxb13a, pik3ca, ptena, rock1, roraa, smad1, tbx5a, tek","ALTERED CARDIOVASCULAR DEVELOPMENT/FUNCTION"
"NUCLEAR RECEPTORS","4","0.00250481290156472","0.259289667412391","7.69","ar, nr1h3, pparab, roraa","ACTIVATION HEPATIC NUCLEAR RECEPTORS"
"ABNORMALITY OF THE MITOCHONDRION","4","0.00279430541457144","0.434237120715719","3.17","ndufs2, ndufv2, pdhx, sdha","INJURY MITOCHONDRIA; DAMAGING MITOCHONDRIA; N/A MITOCHONDRIAL DYSFUNCTION 1"
"GO:0006936","5","0.00281437924025043","0.231932481259619","9.09","calcrla, neurog1, pgam2, pik3ca, rock1","REDUCTION ABDOMINAL MUSCLE CONTRACTION; OVERACTIVATION MUSCLE CONTRACTION"
"REGULATION OF POTASSIUM ION TRANSPORT","3","0.00290698690229537","0.469206240325094","18.75","adcyap1b, atf4a, ptena","INHIBITION ETHER-A-GO-GO ERG VOLTAGE-GATED POTASSIUM CHANNEL"
"GO:0030154","8","0.00298254894064267","0.158970692969833","12.31","agrn, fyna, neurog1, nr1h3, pparab, sox1a, vegfaa, wnt1","DIFFERENTIATION OF MYOFIBROBLAST"
"PARALYSIS","3","0.00313491344849636","0.443985000885691","13.04","sdha, sdhc, tpi1b","INDUCTION SOMATIC MUSCLE PARALYSIS; INDUCTION PHARYNGEAL MUSCLE PARALYSIS"
"GO:0009790","17","0.00323215153078705","0.0696493929570934","10.06","ar, cebpb, ephb2b, grhl2b, hoxb1a, hoxb5a, krt94, neurog1, rdh10a, rock1, rpl38, smad1, tbx5a, tfap2a, tp53, wnt1, xab2","DEFECT OF EMBRYOGENESIS"
"MALE REPRODUCTIVE SYSTEM NEOPLASM","4","0.0032379937059175","0.344499341113973","26.67","ar, ephb2b, ptena, tp53","MALFORMATION MALE REPRODUCTIVE TRACT; INDUCTION MALE REPRODUCTIVE TRACT; MALFORMED MALE REPRODUCTIVE TRACT"
"GO:0007568","7","0.00329934567312249","0.201127521271897","8.14","arntl1a, cat, msh6, ptena, sirt3, tp53, wnt1","ACCELERATED AGING"
"GO:0007059","9","0.00346054642503085","0.115880235106179","20.45","atrx, cdc20, cdc42, ndc1, nup37, nup43, plk1, ppp2r1b, rps3","INCREASED CHROMOSOME MISSEGGREGATION"
"GO:0000003","23","0.00353807776424383","0.055864891851481","11.33","adcyap1b, ar, arntl1a, arrb2b, atrx, calr3a, cdc20, cebpb, grhl2b, hoxb13a, krt94, msh6, ndc1, neurog1, nup107, pgam2, plk1, ppp2r1b, ptena, rdh10a, rpa1, rqcd1, tbp","REDUCED REPRODUCTIVE SUCCESS; REPRODUCTIVE FAILURE"
"GO:0030545","4","0.00365815523300532","0.415236413858938","6.78","adcyap1b, bmp1a, ntf3, wnt1","DESENSITIZATION NICOTINIC ACETYLCHOLINE RECEPTOR"
"GO:0003707","5","0.00366578695374372","0.194272595248197","15.62","ar, nr1h3, pparab, roraa, rorb","REDUCED MATURATION INDUCING STEROID RECEPTOR SIGNALLING OOCYTE"
"LYMPHOCYTE APOPTOTIC PROCESS","2","0.00385168903008927","0.971666231028082","25","ptena, tp53","DECREASED LYMPHOCYTES"
"GO:0003824","8","0.00424356602883781","0.149144747977456","12.31","aldob, atic, ckmt1, gad2, gcat, pgam2, psat1, tpi1b","DECREASED DHB4/HSD17B4; DECREASE INCORPORATION OF ACTIVE IODIDE INTO IODOTYROSINES; INHIBITION PROLYL HYDROXYLASES; INHIBITION UROD; DECREASE AKT/ENOS ACTIVITY; INHIBITION DEIODINASE 2; INHIBITION DEIODINASE 1; INHIBITION IODOTYROSINE DEIODINASE IYD; INHIBITION DEIODINASE 3; INHIBITION DUAL OXIDASE; INDUCTION UPREGULATION OF GLUCURONYLTRANSFERASE ACTIVITY"
"GO:0044703","11","0.00471280969039165","0.111365635245309","9.48","adcyap1b, ar, arntl1a, atrx, calr3a, ndc1, pgam2, plk1, ppp2r1b, ptena, tbp","N/A REPRODUCTIVE FAILURE"
"GLYCOLYSIS AND GLUCONEOGENESIS","3","0.00492712942050165","0.432190828188472","13.04","aldob, pgam2, tpi1b","DECREASED PCK1 EXPRESSION CONTROL POINT FOR GLYCOLYSIS/GLUCONEOGENESIS PATHWAY"
"GO:0046562","4","0.00511815322416714","0.264790603907213","14.81","aldh9a1a.1, aldob, pgam2, tpi1b","DECREASED GLUCOSE OXIDASE ENZYME ACTIVITY"
"PSYCHOGENIC NON EPILEPTIC SEIZURE","4","0.00547570034057909","0.365030869662541","30.77","psmd12, sdha, sdhc, tp53","OCCURRENCE EPILEPTIC SEIZURE"
"GO:0019932","5","0.00567169211877267","0.216903155028907","8.2","adcyap1b, adrb1, calcrla, nme2b.2, ppp2r1b","INCREASED SECOND MESSENGER PRODUCTION"
"OXIDATIVE STRESS","4","0.00593713471069489","0.296380509635318","16.67","cat, gsr, hmox1a, mt2","PROPAGATION OXIDATIVE STRESS; N/A OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASED OXIDATIVE STRESS; INCREASE OXIDATIVE STRESS / ACTIVATION PMK-1 P38 MAPK; INCREASE ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS; INCREASED ENERGETIC DEMANDS AND THEREFORE METABOLIC STRESS"
"GO:0005515","9","0.00594781242002551","0.155415135027734","19.15","arntl1a, bmp1a, cdc42, eif4ea, hsp90aa1.1, neurog1, tbx5a, tp53, vegfaa","BINDING SH-/SELEN-PROTEINS; COVALENT BINDING PROTEIN"
"GO:0004882","3","0.00649254184525793","0.51171601560642","8.57","ar, rchy1, tp53","N/A ANDROGEN RECEPTOR ANTAGONISM; AGONISM ANDROGEN RECEPTOR; DECREASED ANDROGEN RECEPTOR ACTIVITY; ACTIVATION ANDROGEN RECEPTOR"
"HYPERTENSION ASSOCIATED WITH PHEOCHROMOCYTOMA","2","0.00704249915670794","0.837688708758147","28.57","sdha, sdhc","INCREASE HYPERTENSION"
"ELECTRON TRANSPORT CHAIN","7","0.00713192722132801","0.177659912655746","10.29","cox7a2a, gsr, ndufs2, ndufv2, sdha, sdhc, uqcrh","DISRUPTION MITOCHONDRIAL ELECTRON TRANSPORT CHAIN"
"GO:0048469","3","0.00833746871154998","0.392331883517605","12.5","agrn, hoxb13a, ppp2r1b","INCREASED OOCYTE MATURATION"
"SQUAMOUS CELL CARCINOMA","2","0.00876310297329","0.782348512065576","20","fdps, krt94","INCREASE PAPILLOMAS/CARCINOMAS SQUAMOUS CELLS; INCREASE RESPIRATORY OR SQUAMOUS METAPLASIA; SQUAMOUS METAPLASIA ABERRANT BASAL CELLS"
"GO:1903008","3","0.00887028228144936","0.320358485335073","23.08","ctsk, tp53, vdac1","DISRUPTION LYSOSOME"
"GO:0016209","2","0.0178252378526833","0.0569092472502158","18.18","cat, gsr","OXIDATION GLUTATHIONE"
"GO:0022414","4","0.01808225409578","0.337218040046453","11.11","ar, msh6, rpa1, tp53","INCREASED REPRODUCTIVE SUCCESS"
"STEROID HORMONE MEDIATED SIGNALING PATHWAY","3","0.0206817681504401","0.329990644731558","2.94","ar, pparab, rqcd1","DECREASE STEROIDOGENIC ACUTE REGULATORY PROTEIN STAR; DECREASED HSD17B10 EXPRESSION; REDUCED MATURATION INDUCING STEROID PLASMA"
"GO:0030520","2","0.0679595700500249","0.2993514622394","25","ar, rqcd1","ACTIVATION ESTROGEN RECEPTOR ALPHA"
